Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Sep-15 | Sep-16 | Sep-17 | Sep-18 | Sep-19 | Sep-20 | Sep-21 | Sep-22 | Sep-23 | Sep-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 793 | 801 | 826 | 916 | 968 | 964 | 1,111 | 1,247 | 1,276 | 1,315 | | 1,363 |
% Growth | NA | 0.9% | 3.2% | 10.9% | 5.7% | -0.4% | 15.2% | 12.3% | 2.3% | 3.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (547) | (532) | (558) | (626) | (647) | (636) | (750) | (883) | (896) | (856) | | (887) |
Gross Profit | 246 | 269 | 268 | 290 | 321 | 328 | 361 | 364 | 380 | 459 | | 476 |
% Revenue | 31.0% | 33.6% | 32.4% | 31.6% | 33.2% | 34.0% | 32.5% | 29.2% | 29.7% | 34.9% | | 34.9% |
| | | | | | | | | | | | |
Research and Development | (14) | (12) | (15) | (15) | (18) | (18) | (20) | (27) | (29) | (23) | | (23) |
Selling and Marketing | (4) | (4) | (5) | (7) | (7) | (3) | (3) | (6) | (5) | (6) | | (6) |
General and Admin | (143) | (165) | (152) | (161) | (176) | (177) | (212) | (205) | (215) | (223) | | (219) |
Other Inc / (Exp) | (38) | 5 | 4 | 9 | (18) | (10) | (7) | (11) | (7) | (31) | | (25) |
Total Operating Exp | (198) | (176) | (167) | (173) | (219) | (209) | (243) | (249) | (256) | (283) | | (272) |
| | | | | | | | | | | | |
Operating Income | 48 | 93 | 101 | 117 | 102 | 120 | 118 | 116 | 124 | 176 | | 203 |
% Revenue | 6.1% | 11.6% | 12.2% | 12.7% | 10.5% | 12.4% | 10.6% | 9.3% | 9.7% | 13.4% | | 14.9% |
| | | | | | | | | | | | |
Interest Expense | (28) | (24) | (22) | (21) | (20) | (26) | (23) | (17) | (15) | (13) | | (11) |
Pre-tax Income | 21 | 69 | 79 | 96 | 82 | 94 | 95 | 99 | 109 | 163 | | 192 |
Earnings of Discontinued Ops. | 18 | 19 | 69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (8) | (24) | (24) | 10 | (18) | (22) | (25) | (22) | (24) | (48) | | (55) |
Net Income to Company | 31 | 64 | 123 | 106 | 64 | 72 | 70 | 77 | 86 | 116 | | 137 |
% Margin | 3.9% | 8.0% | 14.9% | 11.5% | 6.6% | 7.5% | 6.3% | 6.1% | 6.7% | 8.8% | | 10.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 31 | 64 | 123 | 106 | 64 | 72 | 70 | 77 | 86 | 116 | | 137 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (18) | (19) | (69) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 13 | 45 | 54 | 106 | 64 | 72 | 70 | 77 | 86 | 116 | | 137 |
% Margin | 1.6% | 5.6% | 6.6% | 11.5% | 6.6% | 7.5% | 6.3% | 6.1% | 6.7% | 8.8% | | 10.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.08 | 0.28 | 0.34 | 0.67 | 0.40 | 0.46 | 0.44 | 0.49 | 0.55 | 0.74 | | 0.88 |
Diluted EPS (Continuing Ops) | 0.08 | 0.28 | 0.34 | 0.66 | 0.40 | 0.45 | 0.44 | 0.48 | 0.55 | 0.74 | | 0.87 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 160.50 | 161.30 | 160.10 | 158.20 | 157.80 | 157.80 | 158.40 | 157.40 | 156.30 | 155.90 | | 156.20 |
WA Diluted Shares Out. | 163.20 | 163.40 | 161.80 | 159.70 | 159.00 | 158.60 | 159.20 | 158.00 | 156.80 | 156.90 | | 157.70 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 21 | 69 | 79 | 96 | 82 | 94 | 95 | 99 | 109 | 163 | | 192 |
Addback: Net Interest Expense | 28 | 24 | 22 | 21 | 20 | 26 | 23 | 17 | 15 | 13 | | 11 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 2 | | 0 |
Addback: Depreciation & Amortization | 42 | 38 | 40 | 41 | 50 | 55 | 56 | 58 | 60 | 64 | | 58 |
Addback: Restructuring Charges | 7 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | | (5) |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 16 | | 16 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | (9) | (2) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 2 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 43 | 0 | 0 | 4 | 38 | 13 | 22 | 7 | 10 | 14 | | 14 |
Adjusted EBITDA | 141 | 131 | 140 | 153 | 188 | 187 | 202 | 187 | 194 | 273 | | 289 |
% Margin | 17.7% | 16.3% | 17.0% | 16.6% | 19.4% | 19.4% | 18.2% | 15.0% | 15.2% | 20.8% | | 21.2% |
| | | | | | | | | | | | |
Adjusted EBIT | 99 | 93 | 101 | 112 | 138 | 133 | 145 | 130 | 134 | 210 | | 231 |
% Margin | 12.5% | 11.6% | 12.2% | 12.2% | 14.2% | 13.8% | 13.1% | 10.4% | 10.5% | 16.0% | | 16.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 31 | 64 | 123 | 106 | 64 | 72 | 70 | 77 | 86 | 116 | | 137 |
Addback: Unusual Items | 51 | 0 | 0 | (5) | 36 | 13 | 27 | 14 | 10 | 32 | | 27 |
Less: Tax Benefit of Unusual Items (26%) | (13) | 0 | 0 | 1 | (9) | (3) | (7) | (4) | (3) | (8) | | (7) |
Adjusted Net Income | 68 | 64 | 123 | 102 | 90 | 82 | 90 | 87 | 93 | 140 | | 157 |
% Margin | 8.6% | 8.0% | 14.9% | 11.1% | 9.3% | 8.5% | 8.1% | 7.0% | 7.3% | 10.6% | | 11.5% |